Neurovascular devices market projected to reach $7.01b by 2035

Devices include intracranial stents, embolic coils, flow diverters, guidewires, and catheters.

The global neurovascular devices market will grow from $3.32b in 2024 to $7.01b by 2035, achieving a CAGR of 7.02%, according to ResearchAndMarkets.com

Neurovascular disorders, which disrupt blood flow to the brain and nervous system, are a leading cause of mortality and morbidity worldwide. 

The World Health Organization reports approximately 15 million new cases and 5 million deaths from these conditions each year. 

Key risk factors include unhealthy lifestyles, physical trauma, and congenital abnormalities.

Traditional treatment options, such as open neurosurgery and craniotomy, face challenges including complex procedures and lengthy recovery times. 

In contrast, neurovascular devices, including intracranial stents, embolic coils, flow diverters, and catheters, offer minimally invasive alternatives with better precision and targeted treatment.

The market's growth is also boosting related industries, with companies like Biocoat developing specialized coatings for neurovascular devices.